On ECHEMI
Home > Drugs > Hubei Zhongjia Pharmaceutical Co., Ltd.

Hubei Zhongjia Pharmaceutical Co., Ltd.

  • Founded in:

    2001-03-20
  • Country:

    China China
  • Address:

    No. 6 Huaqiao Road, Tianmen City
  • Tax NO.:

    91429006744629071P
  • Registered Funds:

    10 million yuan
  • Email:

Related Drugs
Compound Sodium Chloride Injection
This product is a compound preparation containing 0.85% sodium chloride, 0.03% potassium chloride and 0.033% calcium chloride.
Name Description Content CAS NO. Registered Holders
Sodium chloride

Maintain normal blood and extracellular fluid volume and osmotic pressure

More

Maintain normal blood and extracellular fluid volume and osmotic pressure

0.85% 7647-14-5 43
Potassium chloride

Supplement potassium ions to maintain the stability of body fluid volume and osmotic pressure

More

Supplement potassium ions to maintain the stability of body fluid volume and osmotic pressure

0.03% 7447-40-7 39
Calcium chloride

Supplement calcium ions to maintain the stability of body fluid volume and osmotic pressure

More

Supplement calcium ions to maintain the stability of body fluid volume and osmotic pressure

0.033% 10043-52-4 29
Ethamethamide injection
Phenolsulfonylamine, chemical name: 2,5-dihydroxybenzenesulfonic acid diethylamine salt
Name Description Content CAS NO. Registered Holders
Etamsylate

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

More

It can cause blood vessels to contract, reduce capillary permeability, enhance platelet aggregation and adhesion, promote platelets to release coagulation active substances, shorten coagulation time, and achieve hemostatic effect.

2624-44-4 11
Cloperidin Hydrochloride Tablets
The content of cloperidine hydrochloride (C20H24ClNOHCl) in this product should be 90.0-110.0% of the labeled amount.
Name Description Content CAS NO. Registered Holders
Cloperastine hydrochloride

It suppresses the cough center and relieves cough, and also has a weak antihistamine effect, without dependence and tolerance. It takes effect 20-30 minutes after taking it, and the effect lasts for 3-4 hours.

More

It suppresses the cough center and relieves cough, and also has a weak antihistamine effect, without dependence and tolerance. It takes effect 20-30 minutes after taking it, and the effect lasts for 3-4 hours.

90.0~110.0%Label quantity 14984-68-0 6
Metronidazole Sodium Chloride Injection
The main ingredient of this product is: metronidazole.
Name Description Content CAS NO. Registered Holders
Metronidazole

Metronidazole has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobes. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus. Actinomycetes, Lactobacillus and Propionibacterium are resistant to this product. Its bactericidal concentration is slightly higher than the inhibitory concentration. This product can also inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytic amoeba can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytic amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. It has a carcinogenic effect on some animals.

More

Metronidazole has a strong antibacterial effect on most anaerobic bacteria, but has no effect on aerobic bacteria and facultative anaerobes. The antibacterial spectrum includes Bacteroides fragilis and other Bacteroides, Fusobacterium, Clostridium perfringens, Eubacterium, Veillonella, Peptococcus and Peptostreptococcus. Actinomycetes, Lactobacillus and Propionibacterium are resistant to this product. Its bactericidal concentration is slightly higher than the inhibitory concentration. This product can also inhibit the redox reaction of amoeba and break the nitrogen chain of the protozoa. In vitro tests have shown that when the drug concentration is 1-2 mg/L, the histolytic amoeba can undergo morphological changes in 6-20 hours and all are killed within 24 hours. When the concentration is 0.2 mg/L, the histolytic amoeba can be killed within 72 hours. This product has a strong effect of killing trichomonas, and its mechanism is unknown. It has a carcinogenic effect on some animals.

443-48-1 39
Acyclovir eye drops
The main ingredient of this product is acyclovir, and its chemical name is: 9-[(2-hydroxyethoxy)methyl]guanine
Name Description Content CAS NO. Registered Holders
Acyclovir

This product is a nucleoside antiviral drug that has a selective inhibitory effect on a variety of herpes viruses (HSV). After acyclovir enters HSV-infected cells, it binds to the specific thymidylate kinase encoded by the virus and is rapidly converted into acyclosine monophosphate, which is then converted into acyclosine diphosphate by the cell guanylate kinase, and then converted into acyclosine triphosphate by other cell enzymes, and competes with guanylate triphosphate to infect herpes simplex virus DNA polymerase, thereby inhibiting viral DNA synthesis. Acyclovir triphosphate is a strong viral DNA polymerase inhibitor, which has an inhibitory effect on the DNA polymerase of five human herpes viruses, namely HSV-1, HSV-2, VZV, CMZ and EBV, and has no effect on normal cells. Its antiviral efficacy is 160 times stronger than that of adenosine.

More

This product is a nucleoside antiviral drug that has a selective inhibitory effect on a variety of herpes viruses (HSV). After acyclovir enters HSV-infected cells, it binds to the specific thymidylate kinase encoded by the virus and is rapidly converted into acyclosine monophosphate, which is then converted into acyclosine diphosphate by the cell guanylate kinase, and then converted into acyclosine triphosphate by other cell enzymes, and competes with guanylate triphosphate to infect herpes simplex virus DNA polymerase, thereby inhibiting viral DNA synthesis. Acyclovir triphosphate is a strong viral DNA polymerase inhibitor, which has an inhibitory effect on the DNA polymerase of five human herpes viruses, namely HSV-1, HSV-2, VZV, CMZ and EBV, and has no effect on normal cells. Its antiviral efficacy is 160 times stronger than that of adenosine.

59277-89-3 50
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.